• Health Conditions

    AstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth

    Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism, subscribe today. AstraZeneca, the British-Swedish pharmaceutical giant, is one of the leaders in the race to bring a COVID-19 vaccine to market, a position that has helped boost its stock to record highs and made it one of the most valuable companies in London’s FTSE 100 index. But the company’s third-quarter earnings, released earlier this week, should be a reality check for investors. While Pascal Soriot, the company’s chief executive officer, said AstraZeneca was on track to deliver results from Phase III clinical trials of its COVID-19 vaccine by the end…

    Comments Off on AstraZeneca’s stock is soaring on COVID, but the pandemic has dented its growth